Search results for '钠离子电池宁德时代 中科海钠 财务数据 成本结构 2024 2025'
100 results
-
miRNA-mediated therapy for the treatment of glaucoma
Investigating the role of micro RNA - thought to be an integral part of the disease mechanism in glaucoma - and explore its therapeutic potential for the condition through pre-clinical testing.
-
Generating improved cells for the treatment of limbal stem cell deficiency
Researchers want to create a bank of “off the shelf” limbal stem cells that could be transplanted into any individual.
-
Identifying novel therapies for inherited eye disease
Investigating photoreceptor death which will act as a basis to identify novel therapies for inherited eye disease.
-
Analysing DNA to provide accurate diagnoses and help predict the outcome of retinoblastoma (Rb)
Researchers are investigating eye fluid samples from retinoblastoma patients to make the test as reliable and cost efficient as possible so it can be introduced into clinical service.
-
Optimising radiosensitivity of uveal melanoma by targeting DNA damage response
Researchers investigate how cancer responds to x-ray therapy proton beam therapy. This will identify drug strategies that can optimise radiotherapy treatment in promoting UM cell killing.
-
Investigating genetics underlying inherited corneal disease
Researchers seek to identify the underlying genetic mutations that cause inherited corneal disease.
-
Investigating the influence of life-long metabolic factors that contribute to age-related sight loss conditions
The aim of this study is to identify changes in metabolism that lead to glaucoma, which in turn could result in new treatments.
-
CRISPR activation for inherited blindness
UCL researchers are using gene-editing technique CRISPRa to replace the damaged OPA1 gene which leads to blindness.
-
Genotype-phenotype study of CRB1-retinopathy
To improve understanding of the natural history (or progression) of inherited retinopathies caused by faults in the CRB1 gene.